# Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System

> **NCT01116180** · NA · COMPLETED · sponsor: **Louise Faerch** · enrollment: 9 (actual)

## Conditions studied

- Type 1 Diabetes
- Hypoglycemia

## Interventions

- **DRUG:** Angiotensin II receptor antagonists (Candesartan)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01116180
- **Lead sponsor:** Louise Faerch
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2012-08
- **Final completion:** 2013-02
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2013-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01116180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01116180, "Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01116180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*